Lv53
1480 积分 2023-12-21 加入
Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials
2小时前
待确认
Effect of Bimagrumab vs Placebo on Body Fat Mass Among Adults With Type 2 Diabetes and Obesity
1天前
待确认
RSM01, a Novel Respiratory Syncytial Virus Monoclonal Antibody: Preclinical Characterization and Results of a First-in-Human, Randomised Clinical Trial
22天前
已完结
Risankizumab for Ulcerative Colitis
26天前
已完结
Safety and pharmacokinetics of IBI112, an IL-23 monoclonal antibody, in Chinese healthy volunteers: a first-in-human phase 1 study
29天前
已完结
Interleukin‐3 stabilizes CD124/IL‐4α surface expression in mast cells via Tyk2 and STAT6
29天前
已完结
Dual targeting of mast cells and TSLP with a bispecific antibody
30天前
已完结
Thymic stromal lymphopoietin (TSLP) is a substrate for tryptase in patients with mastocytosis
30天前
已完结
Chronic Urticaria
1个月前
已完结
Bifunctional Molecules That Induce Both Targeted Degradation and Transcytosis of Extracellular Proteins in Brain Cells
1个月前
已完结
皖公网安备34019202002308
